This guide provides researchers, scientists, and drug development professionals with a comprehensive framework for designing and executing targeted off-target sequencing analyses.
This article provides a detailed, up-to-date exploration of the classification and functional diversity of CRISPR-Cas systems, spanning Types I through VI.
This article provides a detailed technical comparison of CRISPR-Cas9 gene editing and base editing platforms for researchers and drug development professionals.
This article provides a comparative analysis of CRISPR and RNAi screening technologies, focusing on their relative sensitivity in identifying essential genes and novel therapeutic targets.
This article provides a comprehensive, current overview of CRISPR-Cas system toxicity for researchers and drug development professionals.
This article provides a comprehensive analysis of two pioneering high-fidelity CRISPR-Cas9 variants: SpCas9-HF1 and eSpCas9.
This comprehensive review examines the molecular mechanisms of CRISPR spacer acquisition from viral DNA, a foundational adaptive immunity process in prokaryotes.
This comprehensive guide explores CRISPR screening methodologies for identifying genetic interactions and dependencies, essential for modern drug discovery.
This article provides a comprehensive guide to leveraging CRISPR screening for drug discovery and target identification.
This comprehensive guide explores the critical role of sequencing depth in CRISPR screen success, tailored for researchers, scientists, and drug development professionals.